• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大颗粒淋巴细胞白血病:利妥昔单抗治疗反应报告

Large Granular Lymphocytic Leukemia: A Report of Response to Rituximab.

作者信息

Ibrahim Uroosa, Parylo Sara, Kedia Shiksha, Hussein Shafinaz, Atallah Jean Paul

机构信息

Department of Hematology/Oncology, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.

Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.

出版信息

Case Rep Hematol. 2017;2017:7506542. doi: 10.1155/2017/7506542. Epub 2017 Jul 18.

DOI:10.1155/2017/7506542
PMID:28804660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5539931/
Abstract

Large granular lymphocytic (LGL) leukemia is a rare form of low grade leukemia characterized by large cytotoxic T cells or natural killer cells on morphological examination. Immunosuppressive therapy is employed as first-line therapy. Treatment options in refractory cases include the anti-CD52 antibody alemtuzumab and purine analogues. We report a rare case that responded to the anti-CD20 monoclonal antibody rituximab. A 77-year-old female presented with complaints of fatigue, fever, and chills of 3 months' duration. A CBC showed that pancytopenia with an absolute neutrophil count (ANC) was 0. Peripheral blood flow cytometry detected increased number of T cell large granular lymphocytes and T cell receptor rearrangement study detected a clonal T cell population. Bone marrow biopsy showed peripheral T cell lymphoma, most consistent with T-large granulocytic leukemia. The patient was treated with prednisone and oral cyclophosphamide for four months with no response. Thereafter, she received four weekly infusions of rituximab with improvement in her blood counts. A response to rituximab in refractory cases such as ours has been reported and may guide us towards exploring other immune-based therapeutics in this rare disease.

摘要

大颗粒淋巴细胞(LGL)白血病是一种罕见的低度白血病,形态学检查可见大量细胞毒性T细胞或自然杀伤细胞。免疫抑制治疗被用作一线治疗。难治性病例的治疗选择包括抗CD52抗体阿仑单抗和嘌呤类似物。我们报告了一例对抗CD20单克隆抗体利妥昔单抗有反应的罕见病例。一名77岁女性主诉疲劳、发热和寒战3个月。全血细胞计数显示全血细胞减少,绝对中性粒细胞计数(ANC)为0。外周血流式细胞术检测到T细胞大颗粒淋巴细胞数量增加,T细胞受体重排研究检测到克隆性T细胞群体。骨髓活检显示外周T细胞淋巴瘤,最符合T大粒细胞白血病。患者接受泼尼松和口服环磷酰胺治疗4个月无反应。此后,她接受了4次每周一次的利妥昔单抗输注,血细胞计数有所改善。已有报道称像我们这样的难治性病例对利妥昔单抗有反应,这可能会引导我们探索这种罕见疾病的其他基于免疫的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b65/5539931/be0aef2d7bea/CRIHEM2017-7506542.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b65/5539931/be0aef2d7bea/CRIHEM2017-7506542.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b65/5539931/be0aef2d7bea/CRIHEM2017-7506542.001.jpg

相似文献

1
Large Granular Lymphocytic Leukemia: A Report of Response to Rituximab.大颗粒淋巴细胞白血病:利妥昔单抗治疗反应报告
Case Rep Hematol. 2017;2017:7506542. doi: 10.1155/2017/7506542. Epub 2017 Jul 18.
2
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.阿仑单抗治疗T细胞大颗粒淋巴细胞白血病:一项单臂、开放标签的2期研究的中期结果。
Lancet Haematol. 2016 Jan;3(1):e22-9. doi: 10.1016/S2352-3026(15)00227-6. Epub 2015 Dec 17.
3
[Successful treatment of large granular lymphocytic leukemia accompanied by refractory anemia with alemtuzumab].[用阿仑单抗成功治疗伴有难治性贫血的大颗粒淋巴细胞白血病]
Rinsho Ketsueki. 2017;58(12):2392-2396. doi: 10.11406/rinketsu.58.2392.
4
T-cell large granular lymphocyte leukemia presenting as end-stage renal disease: the diagnostic role of flow-cytometric and clonality analysis of the urine sediment.以终末期肾病为表现的T细胞大颗粒淋巴细胞白血病:尿沉渣流式细胞术及克隆性分析的诊断作用
Clin Nephrol. 2009 Feb;71(2):198-202. doi: 10.5414/cnp71198.
5
CD52 expression in T-cell large granular lymphocyte leukemia--implications for treatment with alemtuzumab.CD52在T细胞大颗粒淋巴细胞白血病中的表达——对阿仑单抗治疗的意义
Leuk Lymphoma. 2005 May;46(5):723-7. doi: 10.1080/10428190500052156.
6
Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report.喷司他丁治疗侵袭性T细胞大颗粒淋巴细胞白血病完全缓解:首例病例报告
Stem Cell Investig. 2020 Dec 29;7:24. doi: 10.21037/sci-2020-035. eCollection 2020.
7
Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma.供者源性 T 细胞大颗粒淋巴细胞白血病在 1 例外周 T 细胞淋巴瘤患者中的发生。
J Natl Compr Canc Netw. 2016 Aug;14(8):939-44. doi: 10.6004/jnccn.2016.0100.
8
T-cell large granular lymphocytic (LGL) leukemia consists of CD4/CD8 and CD4/CD8 LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis.T细胞大颗粒淋巴细胞(LGL)白血病由CD4/CD8和CD4/CD8 LGL群体组成,并伴有免疫性血小板减少症、自身免疫性中性粒细胞减少症和单克隆B细胞淋巴细胞增多症。
J Clin Exp Hematop. 2019;59(4):202-206. doi: 10.3960/jslrt.19030.
9
T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.一名63岁患有既往T细胞大颗粒淋巴细胞白血病的女性发生T细胞原淋巴细胞白血病:异时性T细胞白血病,具有不一致的亚群限制(CD4与CD8)和不同的克隆身份。
Pathol Res Pract. 2014 Dec;210(12):1100-5. doi: 10.1016/j.prp.2014.08.005. Epub 2014 Aug 19.
10
T-Cell Large Granular Lymphocytic Leukemia as a Cause for Severe Neutropenia.T细胞大颗粒淋巴细胞白血病作为严重中性粒细胞减少症的一个病因
Cureus. 2020 Sep 1;12(9):e10186. doi: 10.7759/cureus.10186.

引用本文的文献

1
T Cell Repertoire Analysis as a Molecular Signature of the Spectrum of T-LGL Lymphoproliferative Disorders: Tracing the Literature.T细胞受体谱分析作为T大颗粒淋巴细胞增殖性疾病谱的分子特征:文献追踪
Curr Issues Mol Biol. 2025 Apr 8;47(4):264. doi: 10.3390/cimb47040264.
2
Activating mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis.CD8+ T 细胞中的激活突变与类风湿关节炎的血清学阳性相关。
Front Immunol. 2024 Oct 21;15:1466276. doi: 10.3389/fimmu.2024.1466276. eCollection 2024.
3
Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.

本文引用的文献

1
Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report.大颗粒淋巴细胞白血病的非典型无白血病表现:一例报告
Onco Targets Ther. 2016 Dec 19;10:31-34. doi: 10.2147/OTT.S115892. eCollection 2017.
2
A population-based study of large granular lymphocyte leukemia.一项基于人群的大颗粒淋巴细胞白血病研究。
Blood Cancer J. 2016 Aug 5;6(8):e455. doi: 10.1038/bcj.2016.59.
3
Rheumatoid arthritis and associated large granular lymphocytic leukemia--successful treatment with rituximab.类风湿关节炎合并大颗粒淋巴细胞白血病——利妥昔单抗治疗成功
大颗粒淋巴细胞白血病与类风湿关节炎的交集
Front Oncol. 2022 May 13;12:869205. doi: 10.3389/fonc.2022.869205. eCollection 2022.
4
Absorption Characteristics of Combination Medication of Realgar and : Transport across MDCK-MDR1 Cells and Pharmacokinetics in Mice after Oral Administration.雄黄复方药物的吸收特性:经MDCK-MDR1细胞的转运及口服给药后在小鼠体内的药代动力学
Evid Based Complement Alternat Med. 2018 Sep 6;2018:6493630. doi: 10.1155/2018/6493630. eCollection 2018.
Acta Reumatol Port. 2015 Oct-Dec;40(4):384-7.
4
Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy.利妥昔单抗治疗后伴类风湿关节炎的 T 细胞大颗粒淋巴细胞白血病的长期缓解。
Blood. 2013 Aug 29;122(9):1583-6. doi: 10.1182/blood-2013-03-491464. Epub 2013 Jul 18.
5
Very long-lasting remission of refractory T-large granular lymphocytes leukemia and myeloma by lenalidomide treatment.来那度胺治疗难治性 T 大颗粒淋巴细胞白血病和骨髓瘤的长期缓解。
Eur J Haematol. 2013 Aug;91(2):183-6. doi: 10.1111/ejh.12141. Epub 2013 Jun 28.
6
Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment.大颗粒淋巴细胞白血病:分子发病机制、临床表现和治疗。
Hematology Am Soc Hematol Educ Program. 2012;2012:652-9. doi: 10.1182/asheducation-2012.1.652.
7
T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.T 细胞和自然杀伤细胞大颗粒淋巴细胞白血病肿瘤。
Leuk Lymphoma. 2011 Dec;52(12):2217-25. doi: 10.3109/10428194.2011.593276. Epub 2011 Jul 13.
8
How I treat LGL leukemia.我如何治疗 LGL 白血病。
Blood. 2011 Mar 10;117(10):2764-74. doi: 10.1182/blood-2010-07-296962. Epub 2010 Dec 29.
9
Large granular lymphocytic leukaemia pathogenesis and management.大颗粒淋巴细胞白血病的发病机制与治疗。
Br J Haematol. 2011 Feb;152(3):273-83. doi: 10.1111/j.1365-2141.2010.08494.x. Epub 2010 Dec 15.